Supernus Pharmaceuticals, Inc. (SUPN)

50.55 -0.98 (-1.90%) USD  |  NASDAQ  |  May 11, 10:38
More

Supernus Pharmaceuticals Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Eli Lilly & Co. Upgrade